VEGF Injections Best for Diabetic Macular Edema Treatment

Monday, November 9, 2015

VEGF Injections Best for Diabetic Macular Edema Treatment

Diabetic Macular Edema (DME) is a significant cause of vision loss in patients with diabetes and diabetic retinopathy. According to researchers reporting in the American Journal of Ophthalmology reviewing and publishing an analysis of studies on Diabetic Maculopathy published between January 1, 1985 and July 31, 2013, although laser photocoagulation has been the standard treatment for DME for nearly 3 decades, there is increasing evidence that better outcomes can be achieved with anti-Vascular Endothelial Growth Factor (anti-VEGF) injections such as Lucentis® or Eylea®.

In fact, the number of patients with DME gaining an improvement of seeing an additional 10-15 letters on the eye chart was at least 2 times greater for those patients treated with the anti-VEGF injections as compared to being treated with laser treatments. Thus, the researchers concluded that anti-VEGF therapy is superior to laser photocoagulation for treatment of moderate to severe visual impairment caused by DME.

If you or someone you know has diabetes and is concerned about their risk of Diabetic Macular Edema (DME) or Diabetic Retinopathy, it is critical that they have regular dilated eye exams.

Please call D’Ambrosio Eye Care at 800-325-3937, visit D’Ambrosio Eye Care, Google+ or so that we can help recommend an appropriate treatment plan.

D'Ambrosio Eye Care provides eye care for patients throughout greater Boston, central and western Massachusetts with office locations at 479 Old Union Turnpike, Lancaster, Massachusetts 01523, 100 Powder Mill Road, Acton, Massachusetts 01720, 413 Main Street, Athol, Massachusetts 01331 and 74 Main Street, Gardner, Massachusetts 01440.